Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers. Επικοινωνία Submitted by Στέργιος Πολύζος on Δευ, 11/18/2019 - 10:54
